Browse All

Current Filters

CLEAR FILTER x

TITLE

Towards a Standardized Process of Onboarding Advanced Practice Providers into Headache Medicine Practices in the United States

Author:Freeman, Marshall   Cook, Calli   Ailani, Jessica   Ehrlich, Annika   Grosberg, Brian   Samaha, Marielle   Moriarty, Maureen   Secora, Karissa   VanderPluym, Juliana   Birlea, Laur Marius   

Session Name:P1: Headache: Population Health and Outcomes Research  

Topic:Headache  

Program Number:P1.009  

Author Institution:Headache Wellness Center, Greensboro, NC  Emory Healthcare, Atlanta, GA  Medstar Georgetown Neurology, McLean, VA  UCSF Headache Center, San Francisco, CA  Hartford HealthCare Headache Center, West Hartford, CT  Cincinnati Children's Hosp Medl Ctr, Cincinnati, OH  Moriarty Associates, Westminster, MD  Barrow Neurological Institute, Phoenix, AZ  Mayo Clinic, Scottsdale, AZ  University of Colorado, Aurora, CO  

Towards Identifying an Optimal Time for Amyloid Assessment with Donanemab Treatment

Author:Brosch, Jared   Doty, Erin   Gueorguieva, Ivelina   Shcherbinin, Sergey   Chow, Kay   Lu, Ming   Sims, John   Collins, Emily   Mintun, Mark   

Session Name:S23: Innovations in Dementia Treatment  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:S23.004  

Author Institution:Indiana University Health, Indianapolis, IN  Eli Lilly and Company, Indianapolis, IN  

Toxicities and Outcome after CD19-directed Chimeric Antigen Receptor T-cell Therapy for Neurolymphomatosis

Author:Dietrich, Jorg   Karschnia, Philipp   Doubrovinskaia, Sofia   Wick, Wolfgang   Martinez-Lage, Maria   Shankar, Ganesh   Abramson, Jeremy   Frigault, Matthew   Kaulen, Leon   

Session Name:S29: Neuro-oncology  

Topic:Neuro-oncology  

Program Number:S29.010  

Author Institution:Massachusetts General Hospital, Harvard Medical School, Hamilton, MA  University of Heidelberg, Heidelberg, Germany  Massachusetts General Hospital, Harvard Medical School, Boston, MA  

Tracking and Failure Analysis of Explanted Neuromodulation Devices

Author:Veuthey, Tess   Poree, Lawrence   

Session Name:P2: Practice, Policy, and Ethics 2  

Topic:Practice, Policy, and Ethics  

Program Number:P2.012  

Author Institution:Stanford Health Care, Neurology, Palo Alto, CA  UCSF, San Francisco, CA  

Tracking Daily Impact of Generalized Myasthenia Gravis Using Smartphone-Based Digital Biomarkers: Lessons Learned from a 1-Year Study with ME&MGopen

Author:Barnett-Tapia, Carolina   Lehnerer, Sophie   Carment, Loic   Gorin, Clarissa   Ravindra, Dellini   Sellami, Noura   Dutta, Bhaskar   Zinaï, Saad   Howard, James   

Session Name:P9: Neuromuscular and Clinical Neurophysiology (EMG): Preclinical Studies, Drug Safety, and Health Economics  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P9.030  

Author Institution:Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and HumboldtUniversität zu Berlin, Department of Neurology with Experimental Neurology, Charitéplatz 1, 10117 Berlin, Germany, Berlin, Germany  Ad Scientiam, Paris, France, Paris, France  Alexion Pharmaceuticals Inc., Winchester, MA